Company Isodiol International Inc. Canadian Securities Exchange
Equities
ISOL
CA46500L2003
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Health Products
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Sales per region
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 19-02-13 |
Dianne Szigety
SEC | Corporate Secretary | 69 | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Director/Board Member | - | 18-11-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 98,334,359 | 98,334,359 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+37.37% | 6.05B | |
-15.69% | 4.45B | |
-12.46% | 3.06B | |
-0.12% | 3.04B | |
+0.47% | 2.58B | |
+36.06% | 1.79B | |
+0.84% | 1.66B | |
-10.60% | 1.63B | |
-12.03% | 1.54B |